| Bridger: a new framework for de novo transcriptome assembly using RNA-seq data Z Chang, G Li, J Liu, Y Zhang, C Ashby, D Liu, CL Cramer, X Huang Genome biology 16, 1-10, 2015 | 330 | 2015 |
| SPOP mutation drives prostate tumorigenesis in vivo through coordinate regulation of PI3K/mTOR and AR signaling M Blattner, D Liu, BD Robinson, D Huang, A Poliakov, D Gao, S Nataraj, ... Cancer cell 31 (3), 436-451, 2017 | 209 | 2017 |
| FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes EJ Adams, WR Karthaus, E Hoover, D Liu, A Gruet, Z Zhang, H Cho, ... Nature 571 (7765), 408-412, 2019 | 207 | 2019 |
| SPOP mutation leads to genomic instability in prostate cancer G Boysen, CE Barbieri, D Prandi, M Blattner, SS Chae, A Dahija, ... Elife 4, e09207, 2015 | 197 | 2015 |
| Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer D Liu, H Xiong, AE Ellis, NC Northrup, CO Rodriguez Jr, RM O'Regan, ... Cancer research 74 (18), 5045-5056, 2014 | 149 | 2014 |
| CHD1 loss alters AR binding at lineage-specific enhancers and modulates distinct transcriptional programs to drive prostate tumorigenesis MA Augello, D Liu, LD Deonarine, BD Robinson, D Huang, S Stelloo, ... Cancer Cell 35 (4), 603-617. e8, 2019 | 111 | 2019 |
| Impact of the SPOP mutant subtype on the interpretation of clinical parameters in prostate cancer D Liu, M Takhar, M Alshalalfa, N Erho, J Shoag, RB Jenkins, RJ Karnes, ... JCO precision oncology 2, 1-13, 2018 | 51 | 2018 |
| Canine spontaneous head and neck squamous cell carcinomas represent their human counterparts at the molecular level D Liu, H Xiong, AE Ellis, NC Northrup, KK Dobbin, DM Shin, S Zhao PLoS genetics 11 (6), e1005277, 2015 | 50 | 2015 |
| SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG J Shoag, D Liu, M Blattner, A Sboner, K Park, L Deonarine, BD Robinson, ... The Journal of clinical investigation 128 (1), 381-386, 2018 | 45 | 2018 |
| Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes D Liu, JE Shoag, D Poliak, RS Goueli, V Ravikumar, D Redmond, ... Nature communications 11 (1), 1987, 2020 | 40 | 2020 |
| Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network P Dhingra, A Martinez-Fundichely, A Berger, FW Huang, AN Forbes, ... Genome biology 18, 1-23, 2017 | 33 | 2017 |
| Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity I Grbesa, MA Augello, D Liu, DR McNally, CD Gaffney, D Huang, K Lin, ... Cell reports 36 (10), 2021 | 26 | 2021 |
| Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer D Liu, MA Augello, I Grbesa, D Prandi, Y Liu, JE Shoag, RJ Karnes, ... The Journal of clinical investigation, 2021 | 25 | 2021 |
| Whole genome bisulfite sequencing of human spermatozoa reveals differentially methylated patterns from type 2 diabetic patients X Chen, Q Lin, J Wen, W Lin, J Liang, H Huang, L Li, J Huang, F Chen, ... Journal of diabetes investigation 11 (4), 856-864, 2020 | 25 | 2020 |
| G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer C Mukhopadhyay, C Yang, L Xu, D Liu, Y Wang, D Huang, LD Deonarine, ... Nature Communications 12 (1), 6662, 2021 | 20 | 2021 |
| Co-clinical analysis of a genetically engineered mouse model and human prostate cancer reveals significance of NKX3. 1 expression for response to 5α-reductase inhibition A Dutta, S Panja, RK Virk, JY Kim, R Zott, S Cremers, DM Golombos, ... European urology 72 (4), 499-506, 2017 | 18 | 2017 |
| Prognostic value of the SPOP mutant genomic subclass in prostate cancer J Shoag, D Liu, X Ma, C Oromendia, P Christos, K Ballman, C Angulo, ... Urologic Oncology: Seminars and Original Investigations 38 (5), 418-422, 2020 | 17 | 2020 |
| Diversity in androgen receptor action among treatment-naïve prostate cancers is reflected in treatment response predictions and molecular subtypes S Ben-Salem, Q Hu, Y Liu, M Alshalalfa, X Zhao, I Wang, ... European urology open science 22, 34-44, 2020 | 9 | 2020 |
| Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130 OJ Kwon, B Zhang, D Jia, L Zhang, X Wei, Z Zhou, D Liu, KT Huynh, ... Oncogene 41 (9), 1309-1323, 2022 | 7 | 2022 |
| Seg-a software Program for finding somatic copy number alterations in whole genome sequencing data of cancer M Zhang, D Liu, J Tang, Y Feng, T Wang, KK Dobbin, P Schliekelman, ... Computational and structural biotechnology journal 16, 335-341, 2018 | 7 | 2018 |
Christopher BarbieriAssociate Professor of Urology, Weill Cornell Medicine在 med.cornell.edu 的电子邮件经过验证
